(S1 (FRAG (PP (IN On) (NP (NP (DT the) (JJ antiarrhythmic) (NN activity)) (PP (IN of) (NP (NP (CD one) (JJ N-substituted) (JJ Doc_44072_52_62_Chemical) (NN derivative)) (PP (IN of) (NP (NNP Doc_44072_77_134_Chemical))))))) (. .)))
(S1 (S (NP (NP (DT The) (JJ antiarrhythmic) (NN activity)) (PP (IN of) (NP (NP (DT the) (JJ compound) (NNP Doc_44072_180_288_Chemical)) (, ,) (VP (VBN referred) (PP (TO to)) (PP (IN as) (NP (NNP Doc_44072_305_308_Chemical)))) (, ,)))) (VP (AUX is) (VP (VBN studied) (PP (PP (IN on) (NP (NP (JJ anaesthesized) (NNS cats)) (CC and) (NP (JJ Wistar) (NN albino) (NNS rats)))) (, ,) (CONJP (RB as) (RB well) (IN as)) (PP (IN on) (NP (JJ non-anaesthesized) (NNS rabbits)))))) (. .)))
(S1 (S (NP (NP (CD Four) (NNS types)) (PP (IN of) (NP (JJ experimental) (NNP Doc_44072_435_445_Disease)))) (VP (AUX are) (NP (JJ used--with) (NNP Doc_44072_461_466_Chemical)) (, ,) (PP (PP (IN with) (NP (NNP Doc_44072_473_483_Chemical-Doc_44072_484_494_Chemical))) (, ,) (PP (IN with) (NP (NNP Doc_44072_501_515_Chemical))) (CC and) (PP (IN with) (NP (NNP Doc_44072_525_534_Chemical))))) (. .)))
(S1 (S (NP (DT The) (NN compound) (NN Doc_44072_549_552_Chemical)) (VP (AUX is) (VP (VBN introduced) (PP (IN in) (NP (NP (NNS doses)) (PP (IN of) (NP (CD 0.25) (CC and) (CD 0.50) (NN mg/kg))))) (ADVP (ADVP (RB intravenously)) (CC and) (ADVP (NP (CD 10) (NNS mg/kg)) (RB orally))))) (. .)))
(S1 (S (NP (NP (DT The) (JJ compound) (NNS manifests) (NN antiarrhythmic) (NN activity)) (PP (IN in) (NP (NP (DT all) (NNS models)) (PP (IN of) (NP (JJ experimental) (NNP Doc_44072_711_721_Disease)))))) (VP (VBD used) (, ,) (S (VP (VBG causing) (NP (NP (JJS greatest) (NN inhibition)) (PP (IN on) (NP (NP (DT the) (NNP Doc_44072_763_773_Disease)) (VP (VBN induced) (PP (PP (IN by) (NP (NNP Doc_44072_785_795_Chemical-Doc_44072_796_806_Chemical))) (PRN (-LRB- -LRB-) (PP (IN in) (NP (NP (CD 90)) (PP (IN per) (NP (NN cent))))) (-RRB- -RRB-)) (CC and) (PP (IN with) (NP (NNP Doc_44072_833_838_Chemical))) (PRN (-LRB- -LRB-) (PP (IN in) (NP (NP (CD 84)) (PP (IN per) (NP (NN cent))))) (-RRB- -RRB-)))))))))) (. .)))
(S1 (S (NP (NP (DT The) (NNS results)) (VP (VBN obtained))) (VP (AUX are) (VP (VBN associated) (PP (PP (IN with) (NP (DT the) (NN beta-adrenoblocking))) (CC and) (PP (IN with) (NP (NP (DT the) (JJ membrane-stabilizing) (NN action)) (PP (IN of) (NP (DT the) (NN compound)))))))) (. .)))
